ZLD 25.6% 76.0¢ zelira therapeutics limited

Ann: Zelira Meets Primary Endpoints for Insomnia Trial, page-42

  1. BI
    201 Posts.
    lightbulb Created with Sketch. 25
    what kind of a lame announcement title is this ‘Zelira meets primary endpoint bla bla’! They needed to come out with ‘Positive insomnia trial results’ !!!!!
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.